SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
A bottle and pills of Hydroxychloroquine sit on a counter at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. (Photo: George Frey/AFP via Getty Images)
A study published Friday in a prestigious medical journal found that the anti-malarial drug President Donald Trump claims he is currently taking--and has repeatedly urged others to take--is not effective for treating Covid-19 and could increase risk of heart problems and death in coronavirus patients.
The study, published in The Lancet, examined the medical records of 96,000 hospitalized coronavirus patients on six continents and found that "drug regimens of chloroquine or hydroxychloroquine alone or in combination with a macrolide was associated with an increased hazard for clinically significant occurrence of ventricular arrhythmias and increased risk of in-hospital death with Covid-19."
"It's one thing not to have benefit, but this shows distinct harm."
--Eric Topol, Scripps Research Translational Institute
Patients who were given hydroxychloroquine and an antibiotic, a combination Trump has touted, had a 45% increase in risk of death and a 411% increase in risk of heart arrhythmias, the study found. Patients who received hydroxychloroquine alone had a 34% increase in mortality risk and a 137% increase in risk of irregular heartbeat.
The authors found "no evidence" of benefits from hydroxychloroquine in Covid-19 patients--a result that is consistent with the findings of previous studies on the drug, which is most commonly used as a treatment for malaria, lupus, and rheumatoid arthritis.
\u201cNEW Research\u2014No evidence of benefit for #chloroquine and #hydroxychloroquine in #COVID19 patients, urgent randomised trials are needed: finding from a large observational study of nearly 15,000 patients with #COVID19 & 81,000 controls https://t.co/P4YbYVhRDZ\n\nThread (1/4)\u201d— The Lancet (@The Lancet) 1590150545
Eric Topol, a cardiologist and director of the Scripps Research Translational Institute, told the Washington Post that "it's one thing not to have benefit, but this shows distinct harm."
"If there was ever hope for this drug, this is the death of it," said Topol.
Sen. Ed Markey (D-Mass.) tweeted that "the science is clear and the president, as usual, is dangerously wrong."
\u201cThe science is clear and the president, as usual, is dangerously wrong. https://t.co/kUfJ1b6YnB\u201d— Ed Markey (@Ed Markey) 1590151240
The new study comes just days after Trump told reporters that he has been taking hydroxychloroquine daily for over a week in an effort to prevent Covid-19 infection.
"I get a lot of tremendously positive news on the hydroxy," Trump said Tuesday, "and, you know, I say, hey... what do you have to lose?"
Trump has repeatedly promoted the drug as a possible treatment for coronavirus despite warnings from medical professionals that there is no evidence it is effective for Covid-19 patients. Retail sales of hydroxychloroquine reportedly soared in March, the month Trump called the drug a "game changer" for treating coronavirus.
"There is no evidence of benefit and there is evidence of harm," Dr. Rob Davidson, an emergency care physician and executive director of the Committee to Protect Medicare, said after the president claimed he's taking the drug. "Trump is responsible for the deaths of tens of thousands. Let's not add to that number."
On April 24, the Food and Drug Administration cautioned against the use of hydroxychloroquine "outside of the hospital setting or a clinical trial due to risk of heart rhythm problems."
In a segment on NPR earlier this week, medical researchers and others explored the politicization of drug treatments as a sad development to emerge during the Covid-19 pandemic, with many placing the blame squarely at the feet of a president who has sidelined experts while injecting his own uninformed and often ridiculous claims into the national conversation.
Dr. Davey Smith, head of Infectious Diseases and Global Public Health at the University of California San Diego School of Medicine, interviewed on the segment, said, "In reality, the virus doesn't care about politics and science should also not care about politics. I just want an answer one way or the other."
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
A study published Friday in a prestigious medical journal found that the anti-malarial drug President Donald Trump claims he is currently taking--and has repeatedly urged others to take--is not effective for treating Covid-19 and could increase risk of heart problems and death in coronavirus patients.
The study, published in The Lancet, examined the medical records of 96,000 hospitalized coronavirus patients on six continents and found that "drug regimens of chloroquine or hydroxychloroquine alone or in combination with a macrolide was associated with an increased hazard for clinically significant occurrence of ventricular arrhythmias and increased risk of in-hospital death with Covid-19."
"It's one thing not to have benefit, but this shows distinct harm."
--Eric Topol, Scripps Research Translational Institute
Patients who were given hydroxychloroquine and an antibiotic, a combination Trump has touted, had a 45% increase in risk of death and a 411% increase in risk of heart arrhythmias, the study found. Patients who received hydroxychloroquine alone had a 34% increase in mortality risk and a 137% increase in risk of irregular heartbeat.
The authors found "no evidence" of benefits from hydroxychloroquine in Covid-19 patients--a result that is consistent with the findings of previous studies on the drug, which is most commonly used as a treatment for malaria, lupus, and rheumatoid arthritis.
\u201cNEW Research\u2014No evidence of benefit for #chloroquine and #hydroxychloroquine in #COVID19 patients, urgent randomised trials are needed: finding from a large observational study of nearly 15,000 patients with #COVID19 & 81,000 controls https://t.co/P4YbYVhRDZ\n\nThread (1/4)\u201d— The Lancet (@The Lancet) 1590150545
Eric Topol, a cardiologist and director of the Scripps Research Translational Institute, told the Washington Post that "it's one thing not to have benefit, but this shows distinct harm."
"If there was ever hope for this drug, this is the death of it," said Topol.
Sen. Ed Markey (D-Mass.) tweeted that "the science is clear and the president, as usual, is dangerously wrong."
\u201cThe science is clear and the president, as usual, is dangerously wrong. https://t.co/kUfJ1b6YnB\u201d— Ed Markey (@Ed Markey) 1590151240
The new study comes just days after Trump told reporters that he has been taking hydroxychloroquine daily for over a week in an effort to prevent Covid-19 infection.
"I get a lot of tremendously positive news on the hydroxy," Trump said Tuesday, "and, you know, I say, hey... what do you have to lose?"
Trump has repeatedly promoted the drug as a possible treatment for coronavirus despite warnings from medical professionals that there is no evidence it is effective for Covid-19 patients. Retail sales of hydroxychloroquine reportedly soared in March, the month Trump called the drug a "game changer" for treating coronavirus.
"There is no evidence of benefit and there is evidence of harm," Dr. Rob Davidson, an emergency care physician and executive director of the Committee to Protect Medicare, said after the president claimed he's taking the drug. "Trump is responsible for the deaths of tens of thousands. Let's not add to that number."
On April 24, the Food and Drug Administration cautioned against the use of hydroxychloroquine "outside of the hospital setting or a clinical trial due to risk of heart rhythm problems."
In a segment on NPR earlier this week, medical researchers and others explored the politicization of drug treatments as a sad development to emerge during the Covid-19 pandemic, with many placing the blame squarely at the feet of a president who has sidelined experts while injecting his own uninformed and often ridiculous claims into the national conversation.
Dr. Davey Smith, head of Infectious Diseases and Global Public Health at the University of California San Diego School of Medicine, interviewed on the segment, said, "In reality, the virus doesn't care about politics and science should also not care about politics. I just want an answer one way or the other."
A study published Friday in a prestigious medical journal found that the anti-malarial drug President Donald Trump claims he is currently taking--and has repeatedly urged others to take--is not effective for treating Covid-19 and could increase risk of heart problems and death in coronavirus patients.
The study, published in The Lancet, examined the medical records of 96,000 hospitalized coronavirus patients on six continents and found that "drug regimens of chloroquine or hydroxychloroquine alone or in combination with a macrolide was associated with an increased hazard for clinically significant occurrence of ventricular arrhythmias and increased risk of in-hospital death with Covid-19."
"It's one thing not to have benefit, but this shows distinct harm."
--Eric Topol, Scripps Research Translational Institute
Patients who were given hydroxychloroquine and an antibiotic, a combination Trump has touted, had a 45% increase in risk of death and a 411% increase in risk of heart arrhythmias, the study found. Patients who received hydroxychloroquine alone had a 34% increase in mortality risk and a 137% increase in risk of irregular heartbeat.
The authors found "no evidence" of benefits from hydroxychloroquine in Covid-19 patients--a result that is consistent with the findings of previous studies on the drug, which is most commonly used as a treatment for malaria, lupus, and rheumatoid arthritis.
\u201cNEW Research\u2014No evidence of benefit for #chloroquine and #hydroxychloroquine in #COVID19 patients, urgent randomised trials are needed: finding from a large observational study of nearly 15,000 patients with #COVID19 & 81,000 controls https://t.co/P4YbYVhRDZ\n\nThread (1/4)\u201d— The Lancet (@The Lancet) 1590150545
Eric Topol, a cardiologist and director of the Scripps Research Translational Institute, told the Washington Post that "it's one thing not to have benefit, but this shows distinct harm."
"If there was ever hope for this drug, this is the death of it," said Topol.
Sen. Ed Markey (D-Mass.) tweeted that "the science is clear and the president, as usual, is dangerously wrong."
\u201cThe science is clear and the president, as usual, is dangerously wrong. https://t.co/kUfJ1b6YnB\u201d— Ed Markey (@Ed Markey) 1590151240
The new study comes just days after Trump told reporters that he has been taking hydroxychloroquine daily for over a week in an effort to prevent Covid-19 infection.
"I get a lot of tremendously positive news on the hydroxy," Trump said Tuesday, "and, you know, I say, hey... what do you have to lose?"
Trump has repeatedly promoted the drug as a possible treatment for coronavirus despite warnings from medical professionals that there is no evidence it is effective for Covid-19 patients. Retail sales of hydroxychloroquine reportedly soared in March, the month Trump called the drug a "game changer" for treating coronavirus.
"There is no evidence of benefit and there is evidence of harm," Dr. Rob Davidson, an emergency care physician and executive director of the Committee to Protect Medicare, said after the president claimed he's taking the drug. "Trump is responsible for the deaths of tens of thousands. Let's not add to that number."
On April 24, the Food and Drug Administration cautioned against the use of hydroxychloroquine "outside of the hospital setting or a clinical trial due to risk of heart rhythm problems."
In a segment on NPR earlier this week, medical researchers and others explored the politicization of drug treatments as a sad development to emerge during the Covid-19 pandemic, with many placing the blame squarely at the feet of a president who has sidelined experts while injecting his own uninformed and often ridiculous claims into the national conversation.
Dr. Davey Smith, head of Infectious Diseases and Global Public Health at the University of California San Diego School of Medicine, interviewed on the segment, said, "In reality, the virus doesn't care about politics and science should also not care about politics. I just want an answer one way or the other."